{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:40:35Z","timestamp":1773294035039,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,3,7]],"date-time":"2009-03-07T00:00:00Z","timestamp":1236384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s00787-009-0009-8","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T08:19:58Z","timestamp":1236327598000},"page":"511-513","source":"Crossref","is-referenced-by-count":7,"title":["Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disorders"],"prefix":"10.1007","volume":"18","author":[{"given":"Fatma","family":"Varol Tas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taner","family":"Guvenir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,7]]},"reference":[{"key":"9_CR1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00004850-200015010-00002","volume":"15","author":"L Colonna","year":"2000","unstructured":"Colonna L, Saleem P, Dondey-Nouvel L, Rein W (2000) Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group. Int Clin Psychopharmacol 15:13\u201322","journal-title":"Int Clin Psychopharmacol"},{"key":"9_CR2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00787-006-0580-1","volume":"16","author":"PS Jensen","year":"2007","unstructured":"Jensen PS, Buitelaar J, Pandina GJ, Binder C, Haas M (2007) Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials. Eur Child Adolesc Psychiatry 16:104\u2013120","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","volume":"371","author":"RS Kahn","year":"2008","unstructured":"Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IPM et al (2008) Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 371:1085\u20131097","journal-title":"Lancet"},{"key":"9_CR4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2165\/00023210-200418130-00007","volume":"18","author":"K McKeage","year":"2004","unstructured":"McKeage K, Plosker GL (2004) Amisulpride: a review of its use in the management of schizophrenia. CNS Drugs 18:933\u2013956","journal-title":"CNS Drugs"},{"key":"9_CR5","doi-asserted-by":"crossref","unstructured":"Mortimer A, Martin S, L\u00f4o H, Peuskens J, for the Solianol Study Group (2004) A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6\u00a0months in the treatment of schizophrenia. Int Clin Psychopharmacol 19:63\u201369","DOI":"10.1097\/00004850-200403000-00002"},{"key":"9_CR6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00004714-200212000-00004","volume":"22","author":"MJ M\u00fcller","year":"2002","unstructured":"M\u00fcller MJ, Wetzel H, Eich FX, Rein W, Puech A, Benkert O et al (2002) Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia. J Clin Psychopharmacol 22:554\u2013560","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"9_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2147\/tcrm.2007.3.1.3","volume":"3","author":"P Nuss","year":"2007","unstructured":"Nuss P, Hummer M, Tessier C (2007) The use of amisulpride in the treatment of acute psychosis. Ther Clin Risk Manag 3(1):3\u201311","journal-title":"Ther Clin Risk Manag"},{"key":"9_CR8","doi-asserted-by":"crossref","unstructured":"Sechter D, Peuskens J, Fleurot O, Rein W, Lecrubier Y, Amisulpride Study Group (2002) Amisulpride vs. Risperidone in chronic schizophrenia: results of a 6-month double-blind study. Neuropsychopharmacology 27:1071\u20131081","DOI":"10.1016\/S0893-133X(02)00375-5"},{"key":"9_CR9","first-page":"745","volume-title":"Child and adolescent psychiatry. A comprehensive textbook","author":"FR Volkmar","year":"2002","unstructured":"Volkmar FR, Tsatsanis KD (2002) Childhood schizophrenia. In: Lewis M (ed) Child and adolescent psychiatry. A comprehensive textbook. Lippincott Williams & Wilkins, Philadelphia, pp 745\u2013754"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-009-0009-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00787-009-0009-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-009-0009-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:33:25Z","timestamp":1559111605000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00787-009-0009-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,7]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1007\/s00787-009-0009-8","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,7]]}}}